Newstral
Article
The Hindu on 2020-06-05 05:55
Coronavirus | Authors pull controversial Lancet study flagging hydroxychloroquine risks
Related news
- Authors pull study flagging hydroxychloroquine risksvanguardngr.com
- Influential Lancet hydroxychloroquine study retracted by 3 authorsCBC
- NAuthors retract Lancet article that found hydroxychloroquine increases risk of death in COVID-19 patientsnationalpost.com
- Authors retract influential hydroxychloroquine studySan Jose Mercury News
- Authors retract study showing hydroxychloroquine was dangerous for hospitalized COVID-19 patientsAlaska Dispatch News
- Lancet Retracts Study Suggesting Hydroxychloroquine Could Increase Coronavirus Death RiskForbes
- Authors retract divisive hydroxychloroquine study as WHO restarts trialnewatlas.com
- MLancet retracts major hydroxychloroquine study after data inconsistencies surfacedmiamiherald.com
- Lancet study that said malaria drugs led to higher coronavirus death rates retracted as authors say they cannot verify dataSouth China Morning Post
- Despite risks, Trump says he's taking hydroxychloroquinelasvegassun.com
- Despite risks, Trump says he’s taking hydroxychloroquineThe Findlay Courier
- The Risks of Trump’s Hydroxychloroquine HypeThe New York Times
- Authors retract study claiming hydroxychloroquine had fatal side effectsNew York Post
- BCoronavirus: Influential study on hydroxychloroquine withdrawnbbc.co.uk
- Hydroxychloroquine: Dangerous Medicine?northcoastjournal.com
- Hydroxychloroquine linked to increase in COVID-19 deaths, heart risksArs Technica
- Study raising concerns about using hydroxychloroquine to treat virus retractedtimesofisrael.com
- India lifts export ban on hydroxychloroquineThe Hindu